NUVB — Nuvation Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Nuvation Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	119	216	765	661	611
Net Total Receivables	0.828	1.09	3.04	2.48	3.7
Prepaid Expenses
Total Other Current Assets
Total Current Assets	120	221	772	667	616
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.646	0.688	3.66	4.68	4.32
Long Term Investments
Other Long Term Assets
Total Assets	121	222	776	672	621
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	3.2	6.55	16.9	13.2	14
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.2	6.71	30.2	17.1	16.4
Redeemable Preferred Stock
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	118	215	746	655	605
Total Liabilities & Shareholders' Equity	121	222	776	672	621
Total Common Shares Outstanding